Latest DEF 14A proxy statements

First Real Estate Investment Trust of New Jersey, Inc. (FREIT) has announced its annual meeting of stockholders for August 6, 2026, where key matters including director elections and executive compensation will be addressed.

NexGel, Inc. seeks stockholder approval for reincorporation to Nevada, a significant increase in authorized shares, and a discretionary reverse stock split.

FS Specialty Lending Fund has issued its proxy statement for the 2026 Annual Meeting of Shareholders to be held on August 3, 2026.

FS Credit Opportunities Corp. has issued its definitive proxy statement for the 2026 Annual Meeting of Stockholders to be held on August 3, 2026.

Loop Industries announces its 2026 Annual Meeting of Stockholders, scheduled for July 23, 2026, to elect directors, ratify auditors, and vote on equity plan amendments.

Cloudflare, Inc. has issued its proxy statement for the 2026 Annual Meeting of Stockholders, scheduled for June 30, 2026, detailing proposals for director elections, auditor ratification, executive compensation, and amendments to its corporate structure and equity plans.

Gossamer Bio is holding a special meeting of stockholders to vote on several proposals, including an exchange offer for its convertible notes, an amendment to its incentive award plan, and an increase in authorized shares.

Haemonetics Corporation announced its 2026 Annual Meeting of Shareholders will be held on July 24, 2026, to elect directors, approve executive compensation, and ratify auditor appointment.

Singularity Future Technology Ltd. is holding its Annual Meeting on June 30, 2026, to vote on director re-elections, auditor ratification, a new stock incentive plan, a reverse stock split, and an increase in authorized shares.

XMAX Inc. is holding a special meeting on July 24, 2026, to seek stockholder approval for two significant stock issuance proposals aimed at raising capital for AI business development.

Power Solutions International, Inc. has issued its proxy statement for the 2026 Annual Meeting of Stockholders, detailing proposals for director elections, auditor ratification, and executive compensation.

Vivakor, Inc. seeks shareholder approval for significant financing, executive compensation, and potential reverse stock splits.

BiomX Inc. has issued a proxy statement for its 2026 Annual Meeting to elect a director and approve a significant increase in shares reserved for its equity incentive plan.

Graf Global Corp. is requesting shareholder approval to extend its deadline to complete an initial business combination from June 27, 2026, to September 27, 2026, with potential further extensions to December 27, 2026.

Bit Digital, Inc. has issued its 2026 proxy statement detailing proposals for director re-election, quorum changes, and a new equity incentive plan.

Purple Innovation, Inc. is seeking stockholder approval for a reverse stock split to regain compliance with Nasdaq listing requirements.

Tempest Therapeutics is holding a special meeting on June 18, 2026, to seek stockholder approval for the issuance of shares related to warrant exercises, crucial for Nasdaq compliance and company operations.

Achieve Life Sciences announces its 2026 Annual Meeting of Stockholders, detailing proposals including director elections, auditor ratification, executive compensation approval, and a significant increase in authorized shares.

Jazz Pharmaceuticals plc announced its 2026 Annual General Meeting of Shareholders will be held on July 23, 2026, to vote on director elections, auditor ratification, executive compensation, and share issuance authorities.

Rein Therapeutics, Inc. has announced its 2026 Annual Meeting of Stockholders, scheduled for July 20, 2026, to address key corporate matters including director elections and a significant increase in authorized shares.

Constellation Brands announces its 2026 Virtual Annual Meeting of Stockholders, scheduled for July 22, 2026, detailing director nominations, executive compensation, and stock incentive plan amendments.

AmeriServ Financial, Inc. announced its 2026 Annual Meeting of Shareholders will be held virtually on July 23, 2026, to elect directors, vote on executive compensation, and ratify auditors.

Corvex Inc. has announced its 2026 Annual Meeting of Stockholders, scheduled for June 26, 2026, to vote on key proposals including director elections, stock issuances related to a prior merger, auditor ratification, and equity plans.

Artelo Biosciences schedules its 2026 Annual Meeting for July 17, 2026, to elect directors and seek approval to triple authorized common stock.

Curis, Inc. has scheduled a special meeting for June 25, 2026, to seek shareholder approval for a reverse stock split ranging from 1-for-5 to 1-for-25.

DXC Technology's 2026 Proxy Statement outlines director elections, executive compensation, and proposals to extend and increase share reserves for incentive plans.

Radnostix Inc. has issued its proxy statement for the 2026 Annual Meeting of Shareholders, detailing proposals for director elections, auditor ratification, and an incentive plan.

BayFirst Financial Corp. is holding a special meeting on July 14, 2026, to seek shareholder approval for proposals related to its recent $80 million capital raise, including the conversion of preferred stock and an increase in authorized shares.

Ennis, Inc. is holding its 2026 Annual Meeting of Shareholders on July 16, 2026, to elect directors, ratify auditors, and vote on executive compensation.

Decoy Therapeutics Inc. has announced its 2026 Annual Meeting of Stockholders, scheduled for July 14, 2026, to elect directors, vote on executive compensation, and ratify auditor appointment.